426 related articles for article (PubMed ID: 12574391)
1. LF 15-0195 inhibits the development of rat central nervous system autoimmunity by inducing long-lasting tolerance in autoreactive CD4 T cells.
Duplan V; Dutartre P; Mars LT; Liblau RS; Druet P; Saoudi A
J Immunol; 2003 Feb; 170(4):2179-85. PubMed ID: 12574391
[TBL] [Abstract][Full Text] [Related]
2. LF 15-0195 treatment protects against central nervous system autoimmunity by favoring the development of Foxp3-expressing regulatory CD4 T cells.
Duplan V; Beriou G; Heslan JM; Bruand C; Dutartre P; Mars LT; Liblau RS; Cuturi MC; Saoudi A
J Immunol; 2006 Jan; 176(2):839-47. PubMed ID: 16393967
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the antigen specificity and TCR repertoire, and TCR-based DNA vaccine therapy in myelin basic protein-induced autoimmune encephalomyelitis in DA rats.
Miyakoshi A; Yoon WK; Jee Y; Matsumoto Y
J Immunol; 2003 Jun; 170(12):6371-8. PubMed ID: 12794171
[TBL] [Abstract][Full Text] [Related]
4. Dose-dependent mechanisms relate to nasal tolerance induction and protection against experimental autoimmune encephalomyelitis in Lewis rats.
Li HL; Liu JQ; Bai XF; vn der Meide PH; Link H
Immunology; 1998 Jul; 94(3):431-7. PubMed ID: 9767428
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of experimental autoimmune encephalomyelitis in Lewis rats by nasal administration of encephalitogenic MBP peptides: synergistic effects of MBP 68-86 and 87-99.
Liu JQ; Bai XF; Shi FD; Xiao BG; Li HL; Levi M; Mustafa M; Wahren B; Link H
Int Immunol; 1998 Aug; 10(8):1139-48. PubMed ID: 9723700
[TBL] [Abstract][Full Text] [Related]
6. Prevention of experimental allergic encephalomyelitis in rats by targeting autoantigen to B cells: evidence that the protective mechanism depends on changes in the cytokine response and migratory properties of the autoantigen-specific T cells.
Saoudi A; Simmonds S; Huitinga I; Mason D
J Exp Med; 1995 Aug; 182(2):335-44. PubMed ID: 7543135
[TBL] [Abstract][Full Text] [Related]
7. Selective blocking of voltage-gated K+ channels improves experimental autoimmune encephalomyelitis and inhibits T cell activation.
Beeton C; Barbaria J; Giraud P; Devaux J; Benoliel AM; Gola M; Sabatier JM; Bernard D; Crest M; Béraud E
J Immunol; 2001 Jan; 166(2):936-44. PubMed ID: 11145670
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of suppression of experimental autoimmune encephalomyelitis by intravenous administration of myelin basic protein: role of regulatory spleen cells.
Hilliard BA; Kamoun M; Ventura E; Rostami A
Exp Mol Pathol; 2000 Feb; 68(1):29-37. PubMed ID: 10640452
[TBL] [Abstract][Full Text] [Related]
9. Bone marrow-derived dendritic cells from experimental allergic encephalomyelitis induce immune tolerance to EAE in Lewis rats.
Xiao BG; Huang YM; Yang JS; Xu LY; Link H
Clin Exp Immunol; 2001 Aug; 125(2):300-9. PubMed ID: 11529923
[TBL] [Abstract][Full Text] [Related]
10. Effect of timing of intravenous administration of myelin basic protein on the induction of tolerance in experimental allergic encephalomyelitis.
Hilliard B; Ventura ES; Rostami A
Mult Scler; 1999 Feb; 5(1):2-9. PubMed ID: 10096096
[TBL] [Abstract][Full Text] [Related]
11. Acquired tolerance to experimental autoimmune encephalomyelitis by intrathymic injection of myelin basic protein or its major encephalitogenic peptide.
Khoury SJ; Sayegh MH; Hancock WW; Gallon L; Carpenter CB; Weiner HL
J Exp Med; 1993 Aug; 178(2):559-66. PubMed ID: 7688026
[TBL] [Abstract][Full Text] [Related]
12. Impact of 15-deoxyspergualin on effector cells in experimental autoimmune diseases of the nervous system in the Lewis rat.
Jung S; Toyka KV; Hartung HP
Clin Exp Immunol; 1994 Dec; 98(3):494-502. PubMed ID: 7527745
[TBL] [Abstract][Full Text] [Related]
13. Regulation of the effector stages of experimental autoimmune encephalomyelitis via neuroantigen-specific tolerance induction. III. A role for anergy/deletion.
Tan LJ; Vanderlugt CL; McRae BL; Miller SD
Autoimmunity; 1998; 27(1):13-28. PubMed ID: 9482204
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-1 receptor antagonist suppresses experimental autoimmune encephalomyelitis (EAE) in rats by influencing the activation and proliferation of encephalitogenic cells.
Badovinac V; Mostarica-Stojković M; Dinarello CA; Stosić-Grujicić S
J Neuroimmunol; 1998 May; 85(1):87-95. PubMed ID: 9627001
[TBL] [Abstract][Full Text] [Related]
15. T-cell seeding: neonatal transfer of anti-myelin basic protein T-cell lines renders Fischer rats susceptible later in life to the active induction of experimental autoimmune encephalitis.
Volovitz I; Mor F; Machlenkin A; Goldberger O; Marmor Y; Eisenbach L; Cohen IR
Immunology; 2009 Sep; 128(1):92-102. PubMed ID: 19689739
[TBL] [Abstract][Full Text] [Related]
16. Antigen-driven peripheral immune tolerance: suppression of experimental autoimmmune encephalomyelitis and collagen-induced arthritis by aerosol administration of myelin basic protein or type II collagen.
al-Sabbagh A; Nelson PA; Akselband Y; Sobel RA; Weiner HL
Cell Immunol; 1996 Jul; 171(1):111-9. PubMed ID: 8660845
[TBL] [Abstract][Full Text] [Related]
17. Adoptive transfer of experimental allergic encephalomyelitis: recipient response to myelin basic protein-reactive lymphocytes.
Bouwer HG; Hinrichs DJ
J Neuroimmunol; 1994 Oct; 54(1-2):87-98. PubMed ID: 7523447
[TBL] [Abstract][Full Text] [Related]
18. Nasal administration of myelin basic protein prevents relapsing experimental autoimmune encephalomyelitis in DA rats by activating regulatory cells expressing IL-4 and TGF-beta mRNA.
Bai XF; Shi FD; Xiao BG; Li HL; van der Meide PH; Link H
J Neuroimmunol; 1997 Dec; 80(1-2):65-75. PubMed ID: 9413260
[TBL] [Abstract][Full Text] [Related]
19. Antigen-specific down-regulation of myelin basic protein-reactive T cells during spontaneous recovery from experimental autoimmune encephalomyelitis: further evidence of apoptotic deletion of autoreactive T cells in the central nervous system.
Tabi Z; McCombe PA; Pender MP
Int Immunol; 1995 Jun; 7(6):967-73. PubMed ID: 7577805
[TBL] [Abstract][Full Text] [Related]
20. The immunosuppressive agent 15-deoxyspergualin functions by inhibiting cell cycle progression and cytokine production following naive T cell activation.
Holcombe H; Mellman I; Janeway CA; Bottomly K; Dittel BN
J Immunol; 2002 Nov; 169(9):4982-9. PubMed ID: 12391212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
